Related Experiment Videos
Ifosfamide nephrotoxicity in children: histopathological features in two cases
B J Morland1, J R Mann, D V Milford
1Department of Oncology, Children's Hospital, Birmingham, UK.
Medical and Pediatric Oncology
|July 1, 1996
Summary
Two children with rhabdomyosarcoma experienced severe kidney damage after ifosfamide chemotherapy. Renal biopsies revealed specific histopathological changes, highlighting mechanisms of ifosfamide nephrotoxicity.
Area of Science:
- Pediatric Oncology
- Nephrology
- Chemotherapy
Background:
- Rhabdomyosarcoma is a common childhood cancer.
- Ifosfamide is a widely used chemotherapeutic agent for various pediatric malignancies.
- Nephrotoxicity is a known, but not fully understood, side effect of ifosfamide treatment.
Observation:
- Two pediatric patients with rhabdomyosarcoma developed acute kidney injury during ifosfamide-based chemotherapy.
- Clinical presentation included significant electrolyte imbalances requiring supplementation.
- Renal biopsies were performed to investigate the cause of the observed renal dysfunction.
Findings:
- Histopathological examination of renal biopsies revealed specific tubular and interstitial changes consistent with ifosfamide-induced damage.
- Findings suggest a direct toxic effect of ifosfamide metabolites on renal tubular cells.
- The study details the characteristic lesions observed in the affected kidneys.
Implications:
- Understanding the histopathology of ifosfamide nephrotoxicity is crucial for early diagnosis and management.
- This study contributes to elucidating the mechanisms underlying ifosfamide-induced kidney damage in children.
- Findings may inform strategies to mitigate or prevent nephrotoxicity in pediatric cancer patients receiving ifosfamide.